Inlif Ltd is a US-listed company in the industrial machinery & supplies & components industry. Its financial year ends in December.
Loading chart…
Third-party market data · may be delayed
~$0.3
Revenue-to-maturity cash-flow model
Base case. Range ~$0.1–$0.6 across our lower- and higher-growth cases (11.5%–21.5% a year).
No Buy/Hold/Sell rating is issued: only 2 valuation models apply; a rating needs 3.
Inlif Ltd valuation: adjust assumptions and compare models →
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Revenue for the twelve months was $18m. Free-cash-flow margin held at -11.3%. The diluted share count is up 32.6% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades E. It passes 2 of our 3 financial-health checks. Our revenue-to-maturity cash-flow model value is $0.29 a share, against a share price of $0.18.
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Inlif Ltd's trailing-twelve-month revenue grew 16.5% year on year, with a free-cash-flow margin of -11.3%. Where it lags: change in share count of 32.6% ranks 70 of 73 industrial machinery & supplies & components companies we cover.
Current signal Revenue growth decelerating: TTM revenue growth slowed to 16.5% (-8.7pp vs the prior quarter), the 2nd consecutive quarterly slowdown.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
No recent updates are available for INLF from the sources we follow. See filings →
We value Inlif Ltd as an operating company, with every model that fits that kind of business. Cost of equity 9.7%: the 10-year Treasury yield (4.9%) plus a beta of 1.05 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. | ~$0.3 ~$0.1–$0.6 | Primary model, counts double |
| Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. | — | Does not apply: no positive earnings in the latest twelve months |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | ~$0.2 ~$0.1–$0.4 | Included |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | — | Does not apply: return on equity below long-run growth |
| Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. | ~$1.3 ~$1.4–$3.8 | Left out: far from the other models (more than 3x away from their median) |
| Combined value Weighted average of the models that apply: the primary model (revenue-to-maturity model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. | ~$0.3 ~$0.2–$0.3 | 2 models |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Inlif Ltd with Industrial Machinery & Supplies & Components in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
| At fiscal year end | 2025 |
|---|---|
| Share price | $1539.20 |
| Market value | $25.5bn |
| + Net debt (− = net cash) | −$2m |
| Enterprise value | $25.5bn |
| Multiples | |
| Price / sales | n/m |
| Price / earnings | — |
| Price / free cash flow | — |
| EV / EBITDA | — |
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.
No analyst estimates are published for Inlif Ltd: too few analysts cover it.
| Calendar year | 2026 to date |
|---|---|
| Return | |
| INLF | −100% |
| Industry peers (median) | +5% |
| S&P 500 | +11% |
| Months that ended higher | |
| INLF | 36% |
| S&P 500 | 46% |
| Largest fall from a high during the year | |
| INLF | −100% |
| S&P 500 | −9% |
Worst fall since January 2, 2025: 100% from February 14, 2025 to October 26, 2026. Getting back needed a 29031011% gain, and the shares have not yet recovered.
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Revenue (TTM) |
|---|---|
| FY22 Q4 | $6.7M |
| FY23 Q4 | $12.6M |
| FY24 Q4 | $15.8M |
| FY25 Q4 | $18.4M |
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Operating margin (TTM) |
|---|---|
| FY22 Q4 | 9.8% |
| FY23 Q4 | 11.0% |
| FY24 Q4 | 8.2% |
| FY25 Q4 | -31.6% |
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | FCF margin (TTM) |
|---|---|
| FY22 Q4 | 18.4% |
| FY23 Q4 | 1.4% |
| FY24 Q4 | 9.8% |
| FY25 Q4 | -11.3% |
| Fiscal year | 2022 Dec 2022 | 2023 Dec 2023 | 2024 Dec 2024 | 2025 Dec 2025 |
|---|---|---|---|---|
| Income | ||||
| Revenue | 7 | 13 | 16 | 18 |
| Gross profit | 2 | 4 | 5 | 4 |
| EBITDA | 1 | 2 | 2 | −6 |
| Operating income | 1 | 1 | 1 | −6 |
| Net income | 1 | 1 | 2 | −5 |
| Diluted EPS | $0.04 | $0.11 | $0.13 | −$0.33 |
| Growth (year on year) | ||||
| Revenue | — | +89.6% | +25.3% | +16.5% |
| EBITDA | — | +68.8% | −6.7% | −438.0% |
| Operating income | — | +113.1% | −7.0% | −551.8% |
| Net income | — | +151.6% | +18.8% | −439.0% |
| Diluted EPS | — | +175.0% | +18.2% | −353.8% |
| Margins | ||||
| Gross margin | 34.5% | 33.0% | 29.0% | 23.3% |
| EBITDA margin | 15.6% | 13.9% | 10.4% | −30.0% |
| Operating margin | 9.8% | 11.0% | 8.2% | −31.6% |
| Net margin | 8.1% | 10.7% | 10.2% | −29.6% |
| Free-cash-flow margin | 18.4% | 1.4% | 9.8% | −11.3% |
| Cash flow | ||||
| Cash from operations | 1 | 0 | 2 | −2 |
| Capital spending | 0 | 0 | 0 | 0 |
| Free cash flow | 1 | 0 | 2 | −2 |
| Stock-based pay | — | — | — | 5 |
| Free cash flow after stock pay | — | — | — | −7 |
| Balance sheet | ||||
| Cash | 0 | 1 | 2 | 7 |
| Total debt | 0 | 4 | 5 | 5 |
| Net debt (negative = net cash) | −0 | 3 | 2 | −2 |
| Diluted shares | 13m | 13m | 13m | 17m |
| Last 12 months unless stated | INLF | JCSE | AETR | TGEN | FTEK | CVR | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $18m | $16m | $23m | $25m | $27m | $27m | $1.4bn |
| Revenue growth, last 12 months | 16.5% | 7.7% | −42.7% | −6.5% | 8.9% | 7.1% | 8.3% |
| Revenue growth, 3-year average | — | — | −47.8% | 1.8% | −0.6% | −5.2% | 4.0% |
| Revenue growth, latest quarter | — | — | — | −21.2% | 16.7% | −0.8% | 9.1% |
| Gross margin | 23.3% | 28.5% | 11.5% | 36.2% | 44.7% | 11.0% | 35.2% |
| Operating margin | −31.6% | 3.0% | −61.0% | −42.8% | −16.8% | −8.3% | 13.1% |
| Operating margin, 3-year average | — | — | −27.5% | −25.9% | −15.5% | −13.0% | 13.7% |
| Net margin | −29.6% | 15.9% | −264.3% | −42.3% | −12.8% | −8.9% | 8.9% |
| Cash from operations / revenue | −10.3% | 13.2% | −61.1% | −47.2% | −0.8% | −3.6% | 11.9% |
| Free-cash-flow margin | −11.3% | 9.1% | −72.6% | −48.2% | −4.3% | −5.2% | 8.8% |
| Free-cash-flow margin, 3-year average | — | — | −34.8% | −18.7% | −4.0% | −5.3% | 9.8% |
| Stock pay / revenue | 27.9% | 2.4% | 3.5% | 1.8% | 0.8% | — | 0.8% |
| Change in share count | 32.6% | 0.0% | 0.6% | 18.6% | 1.5% | 0.0% | −0.0% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | 16.5% | 8.3% | 19 of 75 |
| Change in growth rate Growth | -8.7pp | +1.2pp | 67 of 75 |
| Gross margin Profitability | 23.3% | 35.4% | 57 of 70 |
| Operating margin Profitability | -31.6% | 13.0% | 69 of 75 |
| Net margin Profitability | -29.6% | 8.9% | 68 of 76 |
| Free-cash-flow margin Cash generation | -11.3% | 9.1% | 69 of 76 |
| Stock pay as % of revenue Cash generation | 27.9% | 0.8% | 67 of 70 |
| Change in share count Balance sheet | 32.6% | -0.0% | 70 of 73 |
| Days sales outstanding Balance sheet | 117 days | 63 days | 62 of 65 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Insider | Date | Trade | Shares | Price | Value |
|---|---|---|---|---|---|
| Hrt Financial Lp 10% owner | July 1, 2026 | Sell | 3,691,666 | $0.03 | $110,750 |
| Hrt Financial Lp 10% owner | June 30, 2026 | Sell | 3,831,240 | $0.06 | $229,874 |
| Hrt Financial Lp 10% owner | June 29, 2026 | Buy | 2,919,237 | $0.06 | $175,154 |
| Hrt Financial Lp 10% owner | June 26, 2026 | Buy | 1,689,946 | $0.06 | $101,397 |
| Hrt Financial Lp 10% owner | June 25, 2026 | Buy | 1,781,958 | $0.03 | $53,459 |
| Hrt Financial Lp 10% owner | June 24, 2026 | Buy | 948,910 | $0.04 | $37,956 |
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
